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Background     There  have  been  few  studies  describing  wound 
infiltration with additional intraarticular administration of mul-
timodal analgesia for total knee arthroplasty (TKA). In this study, 
we  assessed  the  efficacy  of  wound  infiltration  combined  with 
intraarticular regional analgesia with epidural infusion on anal-
gesic requirements and postoperative pain after TKA. 
Methods   40 consecutive patients undergoing elective, primary 
TKA were randomized into 2 groups to receive either (1) intraop-
erative wound infiltration with 150 mL ropivacaine (2 mg/mL), 
1 mL ketorolac (30 mg/mL), and 0.5 mL epinephrine (1 mg/mL) 
(total volume 152 mL) combined with intraarticular infusion (4 
mL/h) of 190 mL ropivacaine (2 mg/mL) plus 2 mL ketorolac (30 
mg/mL) (group A), or (2) epidural infusion (4 mL/h) of 192 mL 
ropivacaine (2 mg/mL) combined with 6 intravenous administra-
tions of 0.5 mL ketorolac (30 mg/mL) for 48 h postoperatively 
(group E). For rescue analgesia, intravenous patient-controlled-
analgesia (PCA) morphine was used. 
Morphine  consumption,  intensity  of  knee  pain  (0–100  mm 
visual analog scale), and side effects were recorded. Length of stay 
and corrected length of stay were also recorded (the day-patients 
fulfilled discharge criteria).
Results   The median cumulated morphine consumption, pain 
scores at rest, and pain scores during mobilization were reduced 
in group A compared to group E. Corrected length of stay was 
reduced by 25% in group A compared to group E.
Interpretation   Peri- and intraarticular analgesia with multi-
modal drugs provided superior pain relief and reduced morphine 
consumption compared with continuous epidural infusion with 
ropivacaine combined with intravenous ketorolac after TKA. 
 
Total knee arthroplasty (TKA) usually results in severe post-
operative  pain.  Continuous  epidural  infusion  with  a  local 
anesthetic  is  a  standard  regime  for  postoperative  analge-
sia after TKA. Epidural analgesia and also peripheral nerve 
block analgesia have been shown to reduce opioid consump-
tion compared with intravenous patient-controlled analgesia 
(PCA). Even though both modalities reduce the occurrence 
of the well-known side effects of opioid drugs, they involve 
extra  equipment  and  are  associated  with  substantial  side 
effects (Choi et al. 2003, Davies et al. 2004, Boezaart 2006). 
Wound infiltration with multimodal analgesia has been a con-
troversial issue for many years (Dahl et al. 1994). Different 
modes of perioperative analgesia either without or combined 
with intraarticular infusion or bolus injection(s) for both TKA 
and total hip arthroplasty have been described (Bianconi et 
al. 2003, Rasmussen et al. 2004, Reilly et al. 2005, Ander-
sen et al. 2007a, b). Only a few studies have described high-
volume  peri-  and  intraarticular  analgesia  for  TKA  (Busch 
et al. 2006, Vendittoli et al. 2006, Toftdahl et al. 2007). The 
hypothesis in our trial was that wound infiltration and intraar-
ticular infusion of ropivacaine and ketorolac would reduce 
opioid consumption during the active treatment period (0–48 
h postoperatively) after TKA compared to epidural infusion of 
ropivacaine and intravenous ketorolac. Primary outcome was 
48-h opioid use. Secondary outcomes included pain at rest 
and during mobilization, side effects, length of hospital stay 
(LOS), and corrected length of stay (the day-patients fulfilled 
discharge criteria).
Patients and methods
With the approval of the Ethics Committee of the County 
of  Copenhagen  (KA-20060134)  and  the  Danish  Medicines 
Agency  (EudraCT.no  2006-004638-33)  and  after  obtain-
ing written informed consent, 40 patients >18 years of age 
undergoing elective, unilateral, primary TKA were enrolled 
in this randomized study. The study fulfilled the requirements 
of the Helsinki Declaration, and was conducted in accordance 
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at Copenhagen University Hospital. It was also registered at 
ClinicalTrial.gov  (NCT00421967)  and  at  the  Danish  Data 
Protection Agency.
Exclusion criteria were hypersensitivity to study drugs, con-
traindications to spinal anesthesia and epidural analgesia, reg-
ular narcotic use, general anesthesia, inability to communicate 
in Danish, drug-treated diabetes, neuropathic pain or sensory 
disorders in the leg to be operated on, rheumatoid arthritis, 
pregnancy, severe obesity (BMI > 40), and treatment with 
tricyclic antidepressants, antiepileptic drugs, and/or antacids. 
Secondary exclusion criteria were failure of spinal anesthesia 
and reoperation or trauma to the knee within the first 48 h 
postoperatively.
Eligible patients were randomized before surgery by using 
a block size of 8 with a ratio of 1:1 according to a computer-
generated sequence, and each patient was assigned by open-
ing a sealed envelope to receive either (1) wound infiltration 
combined with intraarticular infusion (group A) or (2) epidu-
ral infusion and intravenous treatment (group E). 
Patients did not receive any premedication. To reduce blood 
loss, tranexamic acid (10 mg/kg) was given at the beginning of 
surgery and repeated 3 h postoperatively. No surgical drains or 
bladder catheters were used in any of the patients. Spinal anes-
thesia was induced at the L2-3 level by using a 27-gauge spinal 
needle with a dose of 3 mL plain bupivacaine (5 mg/mL). 
In group A, at the end of surgery a mixture of 150 mL 
ropivacaine (2 mg/mL) and 1 mL ketorolac (30 mg/mL) was 
prepared. 50 mL of the solution was loaded into one 50-mL 
syringe.  0.5  mL  epinephrine  (1  mg/mL)  was  added  to  the 
remaining 101 mL, giving a total volume of 102 mL, and 
loaded into two 50-mL syringes, which the surgeon used to 
infiltrate below the capsule, muscles, and subcutaneous tis-
sues. The syringe without epinephrine was used to infiltrate 
skin and subcutis in equal proportions along the whole length 
of the wound. A multi-hole epidural catheter was placed with 
the tip in the joint. The catheter was tunneled 8–10 cm sub-
cutaneously and connected to an infusion pump delivering a 
continuous infusion (flow-rate: 4 mL/h for 48 h) of 190 mL 
ropivacaine (2 mg/mL) at 8 mg/h plus 2 mL ketorolac (30 mg/
mL) at 1.25 mg/h. 
In group E, a combined spinal-epidural technique was used. 
On regression of the spinal block, a test dose of 3 mL lido-
caine-adrenalin (20 mg/mL and 5 µg/mL) was given to con-
firm extradural positioning and this was followed by a bolus 
of 7 mL ropivacaine (2 mg/mL). An infusion pump was con-
nected with a flow rate of 4 mL/h ropivacaine (2 mg/mL, 8 
mg/h) for 48 h postoperatively. 0.5 mL intravenous ketorolac 
(30 mg/mL) was given perioperatively and 3, 20, 28, 34, and 
42 h postoperatively (in a total volume of 3 mL). Both groups 
(E and A) received a total of 90 mg ketorolac during the active 
treatment period.
For rescue analgesia, intravenous PCA morphine (concen-
tration 1 mg/mL, dose 2.5 mg, lockout 10 min) was used. All 
patients  received  oral  acetaminophen  (1,000  mg  4  times  a 
day), starting in the post-anesthesia care unit. For thrombo-
prophylaxis, an injection of 5,000 IE dalteparin was adminis-
tered subcutaneously for 5 days, starting 8 h postoperatively 
on the day of surgery. Ondansetron and metoclopramid were 
used for the treatment of nausea and vomiting. All patients 
received laxatives. At 48 h postoperatively, patients received 
controlled-release oxycodone (10 mg twice daily) and imme-
diate-release oxycodone (5–10 mg). 
Baseline preoperative values were recorded by the anesthe-
siologist for each patient. Surgical time was recorded as the 
interval  between  skin  incision  and  closure.  Supplementary 
cumulated morphine requirements were recorded for 48 h. 
Intensity of knee pain was measured both at rest and during 
coughing (first 4 h after surgery) and at rest and during walk-
ing (6–72 h after surgery) on a 0–100 mm VAS (where 0 = no 
pain, 100 = worst imaginable pain). Assessments of pain, of 
occurrence of nausea and itching on a 3-point numeric rating 
scale (1 = mild, 2 = moderate, 3 = severe), and of vomiting 
and constipation (no bowel function for 72 h) were made by 
patients themselves every 2 h on the day of surgery and every 
4 h on postoperative days 1 to 3, excluding night-time hours. 
The highest of the 4 VAS scores in each interval was used for 
further  analysis.  Urinary  retention  requiring  catheterization 
(bladder ultrasound showing a volume of more than 350 mL) 
was recorded. Total time in the post-anesthesia care unit was 
also recorded. LOS was recorded using standardized discharge 
criteria. Patients were considered for discharge if sufficient 
pain relief was obtained (VAS < 30 mm at rest and < 50 during 
mobilization), if they were able to maintain personal hygiene, 
if they had a basic mobility score of 6 (e.g. were independent 
in being able to get in and out of bed, sit and rise from a chair, 
and walk safely with walking sticks) measured on the cumu-
lated ambulation score (Foss et al. 2006), if they were able to 
climb stairs, and if there was an uncomplicated wound-healing 
process, uncomplicated clinical and radiographic outcomes, 
no evidence of deep vein thrombosis, satisfactory hemoglobin 
level, and at least 90º of knee flexion.
1 month after surgery, each patient was contacted by phone 
by the first author (KVA) for information regarding wound 
complications, infections, and thromboembolic complications.
Statistics
Calculation  of  sample  size  was  based  on  an  expected  dif-
ference of 40% in analgesic consumption. With 80% power 
(α = 0.05, β = 0.2), a sample size of 36 patients per group 
would  be  required. A  conservative  sample  size  of  80  was 
chosen to allow for incomplete data collection. 
Data were analyzed using the Mann-Whitney test, Pearson’s 
chi-squared test, or Fisher’s exact test. Results are reported as 
medians with interquartile range (IQR) or as frequencies. A 
p-value of < 0.05 was considered significant. EpiData, version 
3.1 (EpiData Association, Odense, Denmark) was used for 
data entry, and statistical analysis was performed with STATA 
software version 10.0 (SPSS Inc., Chicago, IL).608  Acta Orthopaedica 2010; 81 (5): 606–610
Results
The protocol was violated regarding sample size. Due to a 
prolonged inclusion period, it was decided to terminate the 
study when 40 patients had completed the protocol. From 
Jan  2007  until  March  2008,  49  patients  were  enrolled  in 
the study; 7 patients (4 patients in group E and 3 patients in 
group A) were withdrawn before receiving any study medi-
cation because of failed spinal anesthesia. 2 patients in group 
E were excluded from the trial after randomization owing 
to an overdose of morphine and failed catheter replacement. 
40 patients completed the study, all with 30-day follow-up 
(Figure).
Baseline data were similar between groups (Table 1). Time 
spent in the postanesthesia care unit was reduced by 75 min 
Flow-chart of the study.
Excluded (n=108)
Refused to participate (n=11)
Contraindication to spinal anesthesia (n=3)
Hypersensitivity to study drugs (n=13)
Neuropathic pain syndrome (n=1)
Inability to communicate in Danish (n=15)
Regular opioid use (n=32)
Severe obesity (n=4)
Patients in treatment with: antacids, tricyclic 
antidepressants or antiepileptic drugs (n=18)
Drug-treated diabetes (n=7)
Rheumatoid arthritis (n=4)
Assessed for eligibility
(n=157)
ALLOCATION
ANALYSIS
FOLLOW-UP
Allocated to group E (n=25)
Received allocated intervention (n=21)
Did not receive allocated intervention
because of conversion to general 
anaesthesia (n=4)
Allocated to group A (n=24)
Received allocated intervention (n=21)
Did not receive allocated intervention
because of conversion to general 
anaesthesia (n=3)
Analyzed (n=19)
Excluded from analysis (n=6)
Analyzed (n=21)
Excluded from analysis (n=3)
Lost to follow-up (n=0)
Discontinued intervention (n=2)
 – morphine overdose (n=1) 
 – failed catheter placement (n=1)
Lost to follow-up (n=0)
Discontinued intervention (n=0)
RANDOMIZED
Table 1. Baseline data
   
  Group A  Group E
   (n = 21)  (n = 19)
Female / Male (n)  9 / 12  5 / 14
Age, years  67 (63–72)  69 (63–74)
Weight, kg  80 (65–89)  85 (71–88)
BMI  28 (25–32)  28 (26–31)
Smoking, yes/no  6 /15  4 /15
ASA physical status 
  I healthy    5    4
  II mild systemic disease  16  13 
  III severe systemic disease    0    2 
Duration of surgery, min  119 (94–139)   109 (85–120)
Values are given as frequencies or median with interquartile range in paren-
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in group A (with a median time (IQR) of 125 (90–154) min as 
opposed to 200 (145–275) min in group E (p < 0.001). 
Morphine consumption during the active treatment period 
(0–48 h) was statistically significantly reduced in group A 
compared to group E (Table 2).
Visual analog pain scores at rest and during mobilization 
were statistically significantly lower in group A than in group 
E during the whole study period, with the exception of pain 
scores during mobilization at 24–48 h after surgery (p = 0.05) 
(Table 3). 
Most adverse events recorded were found to be similar in 
the 2 groups. These included episodes of nausea, vomiting, 
and itching. The intraarticular group (group A) had a signifi-
cantly lower incidence of constipation (p = 0.004) and shorter 
time with urinary retention (p = 0.03). No adverse reactions 
regarding the local anesthetic infiltration and infusion were 
observed.
The median (IQR) length of stay was 4 (3–5) days in group 
A and 4 (4–5) in group E; however, discharge criteria were 
met earlier in group A (3 (3–3.5) days) than in group E (4 
(3–5) days) (p < 0.004). 
One patient in the intraarticular group developed a deep 
infection after a spinal abscess, and 2 patients in the epidural 
group were treated with antibiotics due to wound complica-
tions during the 30-day follow-up. 
Discussion
In this study comparing a peri- and intraarticular technique 
with continuous epidural infusion combined with intravenous 
ketorolac treatment, we found that the former treatment was 
associated with an opioid-sparing effect and reduced intensity 
of pain for 48 h. Time spent in the postanesthesia care unit 
and days until discharge criteria were fulfilled were shorter in 
favour of the peri- and intraarticular technique. We did not find 
any advantage regarding the occurrence of side effects, with 
the exception of constipation and urinary retention. 
Our study has some limitations. Firstly, blinding of patients 
and caregivers was not attempted. Data collection and analy-
sis were carried out by the first author (KVA) who was not 
blinded because catheter placement was obvious. 
This study was inspired by the local infiltration analgesia 
technique developed by Kerr and Kohan (2008). Our findings 
are consistent with the results of 3 recent randomized, con-
trolled trials in knee arthroplasty (Busch et al. 2006, Vendittoli 
et al. 2006, Toftdahl et al. 2007) in which patients received 
either  peri-  or  intraarticular  treatment  or  patient-controlled 
analgesia with opioid or femoral nerve block. All 3 studies 
showed reduced postoperative pain and opioid requirements. 
Patients in this study received 300 mg ropivacaine followed 
by 384 mg over a 48-hour period. None of the patients reported 
any toxic symptoms due to local analgesics. In previous stud-
ies, infiltration with 400 mg ropivacaine without or combined 
with one intraarticular injection of 150 mg ropivacaine has 
shown plasma concentrations far below the toxic level (0.6 
µg/mL) (Busch et al. 2006, Vendittoli et al. 2006). 
Non-steroidal anti-inflammatory drugs are commonly used 
analgesics for minor surgery and are useful adjunctive analge-
sics in patients undergoing major surgery, reducing pain and 
opioid requirements. To our knowledge, this is the first study 
that has had adjustment for the systemic effects of intraarticu-
lar ketorolac. 
2 studies have investigated the effect of continuous intraar-
ticular infusion after TKA (DeWeese et al. 2001, Nechleba et 
al. 2005). Both of them assessed intraarticular infusion with 
bupivacaine compared to PCA epidural analgesia and placebo, 
and they found no or only poor effect. The negative results of 
these 2 studies are not surprising because of the use of drain-
age and relatively low analgesic solutions. To our knowledge, 
there have been no studies investigating the effect of high-
volume periarticular infiltration and continuous intraarticular 
infusion after TKA. 
The quality of analgesia provided by the epidural infusion 
was disappointing. The concept of epidural treatment varies, 
and there is no “gold standard” to which all other treatment 
regimes can be compared, and therefore the epidural regime 
chosen for this study may not be optimal. Epidural analge-
sia can be improved through the synergistic effect of opioids. 
However, Andersen et al. (2007a) found no difference in pain 
intensity scores between peri- and intraarticular injection of 
Table 2. Morphine consumption, mg
   
  Group A (n = 21)  Group E (n = 19)  p-value
0–24 h  7.5 (2.5–15)  18 (13–32)  0.05
24–48 h  5    (0–8.8)  15 (5–23)  0.03
0–48 h  11  (3.8–23)  33 (20–40)  0.01
Values are given as median with interquartile range in parentheses. Mann-
Whitney U test.
Table 3. Pain intensity score (VAS, 0–100 mm) at rest and during 
walking
     
  Group A (n = 21)  Group E (n = 19)  p-value
 
Rest
     2–24    7    (3–25)  30 (10–44)   0.009
   24–48    5    (2–21)  33 (9–38)   0.02
   48–72    7.5 (2.5–21)  23 (14–42)   0.02
Walking
     2–24  13    (4–41)  37 (12–53)   0.05
   24–48  14    (7–35)  41 (27–51)   0.02
   48–72  17   (4.5–36)  41 (24–53)   0.02
Values are given as median with interquartile range in parentheses. Mann-
Whitney U test. 610  Acta Orthopaedica 2010; 81 (5): 606–610
ropivacaine and ketorolac compared with continuous epidural 
infusion of ropivacaine plus morphine in 80 patients after total 
hip arthroplasty. However, they demonstrated an opioid-spar-  However, they demonstrated an opioid-spar- However, they demonstrated an opioid-spar-
ing effect and reduction in side effects using the intraarticular 
administration. 
There has been concern about the risk of infection with the 
use of intraarticular or wound catheters after major orthope-
dic surgery. In this study, 1 patient developed a deep infec-
tion after a spinal abscess during the 30-day follow-up. To our 
knowledge, no studies have had the capacity to investigate the 
potential risk of infection by intraarticular catheters after TKA. 
In a metaanalysis of studies involving continuous infusion of 
local anesthetic into the surgical wound after various surgical 
procedures, Liu et al. (2006) found that there was no statisti-
cally significant difference in wound infection rates between 
patients who received active treatment (0.7%) and those who 
received placebo treatment (1.2%). Studies investigating the 
efficacy of local infiltration analgesia after unicompartmental 
knee arthroplasty or TKA have not found any increased fre-
quency of infections (Bianconi et al. 2003, Vendittoli et al. 
2006, Toftdahl et al. 2007, Essving et al. 2009) but in most 
studies the follow-up period is often very limited.
In conclusion, the intraarticular technique offers advantages 
in its simplicity and minimal risk of complications.
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